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journal homepage: www.elsevier.com/locate/burnsWe appreciated the comments by Dr. Banerjee and Dr. Singh
about our recent paper [1].
In our study, 80 out of 92 isolates of Pseudomonas aeruginosa
that were typed via RAPD-PCR had identical patterns which
were nominated as pattern A and other patterns included only
one or two isolates. Frequencies of ESBL and MBL genes of P.
aeruginosa isolates possessing pattern A have been shown in
Table 1. Among assessed isolates, 26 (32.5%) had OXA-10, TEM
and VIM genes, 14 (17.5%) had OXA-10 and TEM genes and 14
(17.5%) had OXA-10 and VIM genes and due to presence of
producing OXA-10, VIM, PER and IMP beta-lactamases among
isolates with pattern A, the mentioned conclusion has been
cited in the study. On the other hand, in typing methods,
isolates may be similar for genetic patterns but different for
phenotypic characteristics or variety of genes that this
phenomenon may occur due to gene acquiring horizontally [2].
There is not any difference between CLSI 2011 and CLSI
2013 for performing antibiogram, MIC, ESBLs via combina-
tional disk with clavulanic acid and carbapenemase via MHT
methods [3,4]. All conditions for identification of resistance to
polymyxin, ceftazidime, azteronam, cefotaxime, cefepime,
ciprofloxacin and gentamicin are identical between CLSI 2011
and CLSI 2013 [3,4]. Also, since the diameter of clear zoneTable 1 – Distribution of the ESBL and MBL genes among
carbapenem-resistant Pseudomonas aeruginosa RAPD type
A isolates.
Resistance genes Number of isolates
OXA-10 14
IMP 1
TEM + VIM 1
OXA-10 + IMP 2
OXA-10 + TEM 14
OXA-10 + VIM 15
OXA-10 + TEM + PER 2
OXA-10 + TEM + VIM 26
OXA-10 + PER + VIM 3
OXA-10 + TEM + PER + VIM 2
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isolates resistant to carbapenem was zero for imipenem,
meropenem and ertapenem and has been reported as
resistant in this study, therefore there is no difference
between interpretation of results via CLSI 2011 and CLSI
2013 [1,3,4]. The issues raised by Dr. Banerjee and Dr. Singh are
important and should have been addressed in our paper.
However, in all PCR reactions in this study, control isolates
were used but were not cited in the study. Meanwhile, blaAIM
gene with special primer was traced and sequenced (but was
not cited in the study) [5] which possessed 100% similarity
with gene blaAIM recorded as AM998375.1 in GenBank [6].
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